Meloxan

Meloxicam, the active ingredient in Meloxan, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adult patients. GNH USA supplies Meloxan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxan is an NSAID indicated for inflammatory joint diseases and short‑term pain management. - Osteoarthritis: reduces joint pain and inflammation, improving mobility. - Rheumatoid arthritis: alleviates synovial inflammation and slows functional decline. - Ankylosing spondylitis: diminishes spinal pain and stiffness, enhancing posture. - Acute pain: provides rapid relief of moderate to severe pain from musculoskeletal causes.

Adverse reactions may range from mild to serious and should be monitored during therapy.

Common Side Effects: - Gastrointestinal discomfort or dyspepsia - Headache - Dizziness - Peripheral edema - Mild skin rash - Elevated blood pressure

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding - Cardiovascular thrombotic events - Hepatic enzyme elevation or hepatitis - Severe cutaneous reactions (e.g., Stevens‑Johnson syndrome) - Acute renal impairment - Anaphylactic or anaphylactoid reactions

Before initiating therapy, clinicians should consider several safety measures. - Renal function assessment: evaluate baseline creatinine and adjust use in renal impairment. - Blood pressure monitoring: check for hypertension, especially in patients with cardiovascular risk. - Gastrointestinal risk evaluation: avoid in patients with active ulcer disease or history of GI bleeding. - Concomitant anticoagulant use: exercise caution when combined with warfarin or other blood thinners. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Meloxan can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Warfarin or other anticoagulants: increased bleeding risk. - Other NSAIDs or high‑dose aspirin: additive gastrointestinal toxicity. - Lithium: reduced renal clearance leading to lithium toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: potential for reduced renal function. - Diuretics: may enhance nephrotoxic potential, especially in volume‑depleted patients.